Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Development of a rapid functional assay that predicts GLUT1 disease severity.

Zaman SM, Mullen SA, Petrovski S, Maljevic S, Gazina EV, Phillips AM, Jones GD, Hildebrand MS, Damiano J, Auvin S, Lerche H, Weber YG, Berkovic SF, Scheffer IE, Reid CA, Petrou S.

Neurol Genet. 2018 Dec 6;4(6):e297. doi: 10.1212/NXG.0000000000000297. eCollection 2018 Dec.

2.

Clinical and molecular characterization of KCNT1-related severe early-onset epilepsy.

McTague A, Nair U, Malhotra S, Meyer E, Trump N, Gazina EV, Papandreou A, Ngoh A, Ackermann S, Ambegaonkar G, Appleton R, Desurkar A, Eltze C, Kneen R, Kumar AV, Lascelles K, Montgomery T, Ramesh V, Samanta R, Scott RH, Tan J, Whitehouse W, Poduri A, Scheffer IE, Chong WKK, Cross JH, Topf M, Petrou S, Kurian MA.

Neurology. 2018 Jan 2;90(1):e55-e66. doi: 10.1212/WNL.0000000000004762. Epub 2017 Dec 1.

3.

Method of derivation and differentiation of mouse embryonic stem cells generating synchronous neuronal networks.

Gazina EV, Morrisroe E, Mendis GDC, Michalska AE, Chen J, Nefzger CM, Rollo BN, Reid CA, Pera MF, Petrou S.

J Neurosci Methods. 2018 Jan 1;293:53-58. doi: 10.1016/j.jneumeth.2017.08.018. Epub 2017 Aug 18.

PMID:
28827162
4.

Electrophysiological and gene expression characterization of the ontogeny of nestin-expressing cells in the adult mouse midbrain.

Dey A, Farzanehfar P, Gazina EV, Aumann TD.

Stem Cell Res. 2017 Aug;23:143-153. doi: 10.1016/j.scr.2017.07.001. Epub 2017 Jul 4.

5.

Rare and common epilepsies converge on a shared gene regulatory network providing opportunities for novel antiepileptic drug discovery.

Delahaye-Duriez A, Srivastava P, Shkura K, Langley SR, Laaniste L, Moreno-Moral A, Danis B, Mazzuferi M, Foerch P, Gazina EV, Richards K, Petrou S, Kaminski RM, Petretto E, Johnson MR.

Genome Biol. 2016 Dec 13;17(1):245.

6.

Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy.

Corbett MA, Bellows ST, Li M, Carroll R, Micallef S, Carvill GL, Myers CT, Howell KB, Maljevic S, Lerche H, Gazina EV, Mefford HC, Bahlo M, Berkovic SF, Petrou S, Scheffer IE, Gecz J.

Neurology. 2016 Nov 8;87(19):1975-1984. Epub 2016 Oct 12.

7.

A targeted resequencing gene panel for focal epilepsy.

Hildebrand MS, Myers CT, Carvill GL, Regan BM, Damiano JA, Mullen SA, Newton MR, Nair U, Gazina EV, Milligan CJ, Reid CA, Petrou S, Scheffer IE, Berkovic SF, Mefford HC.

Neurology. 2016 Apr 26;86(17):1605-12. doi: 10.1212/WNL.0000000000002608. Epub 2016 Mar 30.

8.

PRIMA1 mutation: a new cause of nocturnal frontal lobe epilepsy.

Hildebrand MS, Tankard R, Gazina EV, Damiano JA, Lawrence KM, Dahl HH, Regan BM, Shearer AE, Smith RJ, Marini C, Guerrini R, Labate A, Gambardella A, Tinuper P, Lichetta L, Baldassari S, Bisulli F, Pippucci T, Scheffer IE, Reid CA, Petrou S, Bahlo M, Berkovic SF.

Ann Clin Transl Neurol. 2015 Aug;2(8):821-30. doi: 10.1002/acn3.224. Epub 2015 Jul 3.

9.

'Neonatal' Nav1.2 reduces neuronal excitability and affects seizure susceptibility and behaviour.

Gazina EV, Leaw BT, Richards KL, Wimmer VC, Kim TH, Aumann TD, Featherby TJ, Churilov L, Hammond VE, Reid CA, Petrou S.

Hum Mol Genet. 2015 Mar 1;24(5):1457-68. doi: 10.1093/hmg/ddu562. Epub 2014 Nov 6.

PMID:
25378553
10.

GABRA1 and STXBP1: novel genetic causes of Dravet syndrome.

Carvill GL, Weckhuysen S, McMahon JM, Hartmann C, Møller RS, Hjalgrim H, Cook J, Geraghty E, O'Roak BJ, Petrou S, Clarke A, Gill D, Sadleir LG, Muhle H, von Spiczak S, Nikanorova M, Hodgson BL, Gazina EV, Suls A, Shendure J, Dibbens LM, De Jonghe P, Helbig I, Berkovic SF, Scheffer IE, Mefford HC.

Neurology. 2014 Apr 8;82(14):1245-53. doi: 10.1212/WNL.0000000000000291. Epub 2014 Mar 12.

11.

KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine.

Milligan CJ, Li M, Gazina EV, Heron SE, Nair U, Trager C, Reid CA, Venkat A, Younkin DP, Dlugos DJ, Petrovski S, Goldstein DB, Dibbens LM, Scheffer IE, Berkovic SF, Petrou S.

Ann Neurol. 2014 Apr;75(4):581-90. doi: 10.1002/ana.24128. Epub 2014 Apr 14.

12.

Computational Analysis of Amiloride Analogue Inhibitors of Coxsackievirus B3 RNA Polymerase.

Holien JK, Gazina EV, Elliott RW, Jarrott B, Cameron CE, Williams SJ, Parker MW, Petrou S.

J Proteomics Bioinform. 2014;Suppl 9:004. doi: 10.4172/jpb.S9-004. Epub 2014 Aug 12.

13.

Viral targets of acylguanidines.

Gazina EV, Petrou S.

Drug Discov Today. 2012 Sep;17(17-18):1039-43. doi: 10.1016/j.drudis.2012.05.002. Epub 2012 May 8. Review.

PMID:
22580299
14.

Amiloride is a competitive inhibitor of coxsackievirus B3 RNA polymerase.

Gazina EV, Smidansky ED, Holien JK, Harrison DN, Cromer BA, Arnold JJ, Parker MW, Cameron CE, Petrou S.

J Virol. 2011 Oct;85(19):10364-74. doi: 10.1128/JVI.05022-11. Epub 2011 Jul 27.

15.

Differential expression of exon 5 splice variants of sodium channel alpha subunit mRNAs in the developing mouse brain.

Gazina EV, Richards KL, Mokhtar MB, Thomas EA, Reid CA, Petrou S.

Neuroscience. 2010 Mar 10;166(1):195-200. doi: 10.1016/j.neuroscience.2009.12.011. Epub 2009 Dec 17.

PMID:
20006674
16.

Heat opens axon initial segment sodium channels: a febrile seizure mechanism?

Thomas EA, Hawkins RJ, Richards KL, Xu R, Gazina EV, Petrou S.

Ann Neurol. 2009 Aug;66(2):219-26. doi: 10.1002/ana.21712.

PMID:
19743470
17.

Amiloride derivatives inhibit coxsackievirus B3 RNA replication.

Harrison DN, Gazina EV, Purcell DF, Anderson DA, Petrou S.

J Virol. 2008 Feb;82(3):1465-73. Epub 2007 Nov 21.

18.

Generalized epilepsy with febrile seizures plus-associated sodium channel beta1 subunit mutations severely reduce beta subunit-mediated modulation of sodium channel function.

Xu R, Thomas EA, Gazina EV, Richards KL, Quick M, Wallace RH, Harkin LA, Heron SE, Berkovic SF, Scheffer IE, Mulley JC, Petrou S.

Neuroscience. 2007 Aug 10;148(1):164-74. Epub 2007 Jul 12.

PMID:
17629415
19.

A childhood epilepsy mutation reveals a role for developmentally regulated splicing of a sodium channel.

Xu R, Thomas EA, Jenkins M, Gazina EV, Chiu C, Heron SE, Mulley JC, Scheffer IE, Berkovic SF, Petrou S.

Mol Cell Neurosci. 2007 Jun;35(2):292-301. Epub 2007 Mar 13.

PMID:
17467289
20.

Ion transport blockers inhibit human rhinovirus 2 release.

Gazina EV, Harrison DN, Jefferies M, Tan H, Williams D, Anderson DA, Petrou S.

Antiviral Res. 2005 Aug;67(2):98-106.

PMID:
16054245
21.

Differential requirements for COPI coats in formation of replication complexes among three genera of Picornaviridae.

Gazina EV, Mackenzie JM, Gorrell RJ, Anderson DA.

J Virol. 2002 Nov;76(21):11113-22.

22.
23.

Normal phosphorylation of duck hepatitis B virus L protein is dispensable for infectivity.

Grgacic EV, Lin B, Gazina EV, Snooks MJ, Anderson DA.

J Gen Virol. 1998 Nov;79 ( Pt 11):2743-51.

PMID:
9820150
24.

Intracellular retention of duck hepatitis B virus large surface protein is independent of preS topology.

Gazina EV, Lin B, Gallina A, Milanesi G, Anderson DA.

Virology. 1998 Mar 15;242(2):266-78.

25.

[Preparation and purification of a polypeptide containing antigenic determinants of hepatitis C core protein].

Petrakova NV, Kalinina TI, Khudiakov IuE, Gazina EV, Smirnov VD.

Vopr Virusol. 1997 Sep-Oct;42(5):208-12. Russian.

PMID:
9424844
26.

[Expression in Escherichia coli of hepatitis B virus polymerase and its functional domains].

Gazina EV, Semiletov IuA, Markova NV, Pavliuchenkova RP.

Mol Gen Mikrobiol Virusol. 1994 Mar-Apr;(2):21-4. Russian.

PMID:
8183303
27.

The effect of the structure of the terminal regions of the hepatitis B virus gene C polypeptide on the formation of core antigen (HBcAg) particles.

Khudyakov YuE, Kalinina TI, Neplyueva VS, Gazina EV, Kadoshnikov YuP, Bogdanova SL, Smirnov VD.

Biomed Sci. 1991;2(3):257-65.

PMID:
1751758

Supplemental Content

Loading ...
Support Center